Thus, before demonstrating that AMPK activation can mediate PCAF upregulation to induce H3K9ac hyperacetylation and thus inhibit cervical cancer growth, it is necessary to determine whether PCAF inhibits cervical cancer proliferation. Here, PRKAA1 is linked to cervical carcinoma.